Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

OpGen Subsidiary Ares Genetics Maintains Patent Titled 'Genetic Resistance Prediction Against Antimicrobial Drugs In Microorganism Using Structural Changes In The Genome' In Europe

Author: Bill Haddad | June 26, 2023 07:37am

Posted In: SYNH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist